ReachMD

Be part of the knowledge.™

Pathology and Laboratory Medicine

195

LikeLikedUnlike

Episodes 16-30 of 84

Molecular-Driven Treatment Advances in HER2+ Metastatic Colorectal Cancer
CME/CE
Molecular-Driven Treatment Advances in HER2+ Metastatic Colorectal Cancer
- Tanios S. Bekaii-Saab, MD
  Peer
- Joleen M. Hubbard, MD
  Peer
0.25 credits
Recent Advances and Emerging Approaches in the Treatment of Recurrent/Metastatic SCCHN: Matching the Patient to the Optimal Therapy
CME/CE
Recent Advances and Emerging Approaches in the Treatment of Recurrent/Metastatic SCCHN: Matching the Patient to the Optimal Therapy
- Ezra Cohen, MD, FRCPSC, FASCO
  Peer
- Petr Szturz, MD, PhD
  Peer
0.25 credits
Transforming Cervical Cancer Screening and Management: New Guidelines, New Tests
A Case-Based Discussion
CME/CE
Transforming Cervical Cancer Screening and Management: New Guidelines, New Tests
A Case-Based Discussion
- Warner K. Huh, MD
  Peer
- Leigh Anne Cantrell, MD, MSPH
  Peer
- Mark H. Stoler, MD
  Peer
0.50 credits
Selecting and Sequencing Immunotherapies for Patients with Advanced RCC
CME/CE
Selecting and Sequencing Immunotherapies for Patients with Advanced RCC
- Eric Jonasch, MD
  Peer
- Brad McGregor, MD
  Peer
0.50 credits
Current Standards and Future Opportunities for ADCs in Advanced/Metastatic Triple-Negative Breast Cancer
CME/CE
Current Standards and Future Opportunities for ADCs in Advanced/Metastatic Triple-Negative Breast Cancer
- William J. Gradishar, MD
  Peer
- Javier Cortes, MD, PhD
  Peer
- Hope S. Rugo, MD, FASCO
  Peer
0.50 credits
Current and Emerging Roles of Immunotherapy and ADCs for Patients with Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer
CME/CE
Current and Emerging Roles of Immunotherapy and ADCs for Patients with Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer
- Mamta Parikh, MD, MS
  Peer
- Daniel P. Petrylak, MD
  Peer
0.50 credits
Symptoms of Systemic Mastocytosis
Minute CME/CE™
Symptoms of Systemic Mastocytosis
- Mariana C. Castells, MD, PhD
  Peer
1.25 program credits
Multidisciplinary Approach to Making the Diagnosis of Systemic Mastocytosis
Minute CME/CE™
Multidisciplinary Approach to Making the Diagnosis of Systemic Mastocytosis
- Mariana C. Castells, MD, PhD
  Peer
1.25 program credits
How Should I Evaluate Treatment Responses in Non-Advanced Systemic Mastocytosis?
Minute CME/CE™
How Should I Evaluate Treatment Responses in Non-Advanced Systemic Mastocytosis?
- Matthew P. Giannetti, MD
  Peer
1.25 program credits
Current Guidelines and Management of Non-Advanced Systemic Mastocytosis
Minute CME/CE™
Current Guidelines and Management of Non-Advanced Systemic Mastocytosis
- Matthew P. Giannetti, MD
  Peer
1.25 program credits
Minute CME/CE™
Expert Insights Into the Epidemiology, Diagnosis, and Treatment of Non-Advanced Systemic Mastocytosis
- Mariana C. Castells, MD, PhD
  Peer
- Matthew P. Giannetti, MD
  Peer
1.25 credits 7 episodes
Targeted Therapy for Non-Advanced Systemic Mastocytosis
Minute CME/CE™
Targeted Therapy for Non-Advanced Systemic Mastocytosis
- Matthew P. Giannetti, MD
  Peer
1.25 program credits
Changing the Treatment Paradigm: Taking a Targeted Approach to Treating Non-Advanced Systemic Mastocytosis
Minute CME/CE™
Changing the Treatment Paradigm: Taking a Targeted Approach to Treating Non-Advanced Systemic Mastocytosis
- Mariana C. Castells, MD, PhD
  Peer
- Matthew P. Giannetti, MD
  Peer
1.25 program credits
The Many Clinical Presentations of Non-Advanced Systemic Mastocytosis
Minute CME/CE™
The Many Clinical Presentations of Non-Advanced Systemic Mastocytosis
- Mariana C. Castells, MD, PhD
  Peer
1.25 program credits
Utilization and Management of Antibody-Drug Conjugates in Metastatic Breast Cancer: The Relationship Between ADCs and HER2
CME/CE
Utilization and Management of Antibody-Drug Conjugates in Metastatic Breast Cancer: The Relationship Between ADCs and HER2
- William J. Gradishar, MD
  Peer
- Javier Cortes, MD, PhD
  Peer
- Hope S. Rugo, MD, FASCO
  Peer
0.50 credits

Program Chapters

Segment Chapters

Playlist:

Recommended